Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Form DEFA14A: Additional definitive proxy soliciting materials

VivoSim Labs, Inc. Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-11-03: Form DEFA14A; Description DEFA14A; Document vivs_defa_14a_2025.htm.
  • 2024-10-07: Form DEFA14A; Description DEFA14A; Document onvo_defa_14a_2024.htm.
  • 2023-09-13: Form DEFA14A; Description DEFA14A; Document onvo_defa_14a_2023.htm.
  • 2022-09-22: Form DEFA14A; Description DEFA14A; Document onvo-defa14a_20221012.htm.
FiledFormPeriod of reportDescriptionDocument
2025-11-03DEFA14ADEFA14Avivs_defa_14a_2025.htm
2024-10-07DEFA14ADEFA14Aonvo_defa_14a_2024.htm
2023-09-13DEFA14ADEFA14Aonvo_defa_14a_2023.htm
2022-09-22DEFA14ADEFA14Aonvo-defa14a_20221012.htm
2022-07-26DEFA14ADEFA14Aonvo-defa14a_20220907.htm
2021-09-17DEFA14ADEFA14Ad125915ddefa14a.htm
2021-08-31DEFA14ADEFA14Aonvo-defa14a_20210914.htm
2021-08-05DEFA14ADEFA14Aonvo-defa14a_20210914.htm
2020-09-03DEFA14ADEFA14Aonvo-defa14a_20200915.htm
2020-08-17DEFA14ADEFA14Aonvo-defa14a_20200326.htm
2020-08-06DEFA14ADEFA14Aonvo-defa14a_20200915.htm
2020-07-15DEFA14A8-Kd931793d8k.htm
2019-08-07DEFA14A8-Konvo-8k_20190807.htm
2019-07-26DEFA14ADEFA14Aonvo-defa14a_20190331.htm
2018-06-15DEFA14ADEFA14Aonvo-defa14a_20180726.htm
2017-07-14DEFA14ADEFA14Ad410084ddefa14a.htm
2016-07-08DEFA14ADEFA14Ad164021ddefa14a.htm
2015-07-10DEFA14ADEFA14Ad12188ddefa14a.htm
2014-07-11DEFA14ADEFA14Ad748289ddefa14a.htm
2013-07-12DEFA14ADEFA14Ad566332ddefa14a.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70